Literature DB >> 21863660

Can valvular interstitial cells become true osteoblasts? A side-by-side comparison.

Elyssa L Monzack1, Kristyn S Masters.   

Abstract

BACKGROUND AND AIM OF THE STUDY: Aortic valve calcification is believed to involve the differentiation of valvular interstitial cells (VICs) into either a myofibroblastic or an osteoblast-like phenotype. Despite purported similarities between diseased VICs and osteoblasts, few studies have directly compared VICs and osteoblasts in side-by-side experiments. In the present study, VICs were compared against multiple osteoblastic cell types at different stages of differentiation. These findings may help to resolve whether VICs progress through a myofibroblastic phenotype before reaching an osteoblast-like stage.
METHODS: Three cell types representing a range of osteoblastic lineage commitment and differentiation were used in the phenotypic comparison against VICs. Specifically, VICs, embryonic fibroblasts (C3H10T1/2), pre-osteoblasts (MC3T3-E1), and mature primary osteoblasts were cultured on tissue-culture polystyrene in control or mineralization medium, and harvested for qPCR, DNA, and protein analysis at time points ranging from one to eight days.
RESULTS: Culture of VICs in mineralization medium decreased the expression of alpha-smooth muscle actin (alpha-SMA; a myofibroblast marker), with no peak in alpha-SMA gene or protein expression in mineralization medium at any time point. The application of a mineralization medium led to increased expression levels of alkaline phosphatase (ALP; an early mineralization marker) for all cell types, although the magnitude of the increase in ALP was drastically smaller for VICs than for the osteogenic cell types. Only the osteogenic cell types demonstrated an appreciable increase in osteocalcin (an indicator of later-stage mineralization).
CONCLUSION: While the addition of mineralization medium generally increased the expression of osteogenic markers and decreased the expression of myofibroblastic markers, VICs displayed different levels and patterns of expression than the osteoblastic cell types used for comparison. Additionally, the lack of an alpha-SMA increase at any point after the addition of mineralization medium to VICs indicated that these cells may not need to progress through a myofibroblastic stage before reaching an osteoblast-like gene expression profile.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21863660      PMCID: PMC3285463     

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  28 in total

Review 1.  The cardiac valve interstitial cell.

Authors:  Patricia M Taylor; Puspa Batten; Nigel J Brand; Penny S Thomas; Magdi H Yacoub
Journal:  Int J Biochem Cell Biol       Date:  2003-02       Impact factor: 5.085

2.  Osteoblast isolation from murine calvariae and long bones.

Authors:  Astrid Bakker; Jenneke Klein-Nulend
Journal:  Methods Mol Med       Date:  2003

3.  Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division.

Authors:  C A Reznikoff; D W Brankow; C Heidelberger
Journal:  Cancer Res       Date:  1973-12       Impact factor: 12.701

4.  Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division.

Authors:  C A Reznikoff; J S Bertram; D W Brankow; C Heidelberger
Journal:  Cancer Res       Date:  1973-12       Impact factor: 12.701

5.  Porcine cardiac valvular subendothelial cells in culture: cell isolation and growth characteristics.

Authors:  C M Johnson; M N Hanson; S C Helgeson
Journal:  J Mol Cell Cardiol       Date:  1987-12       Impact factor: 5.000

6.  Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential.

Authors:  D Wang; K Christensen; K Chawla; G Xiao; P H Krebsbach; R T Franceschi
Journal:  J Bone Miner Res       Date:  1999-06       Impact factor: 6.741

7.  Ultrastructure of cardiovascular lesions induced by hypervitaminosis D and its withdrawal.

Authors:  S Taura; M Taura; H Imai; F A Kummerow; K Tokuyasu; S B Cho
Journal:  Paroi Arterielle       Date:  1978-10

8.  Vitamin D-induced coronary atherosclerosis in normolipemic swine: comparison with human disease.

Authors:  S Taura; M Taura; A Kamio; F A Kummerow
Journal:  Tohoku J Exp Med       Date:  1979-09       Impact factor: 1.848

Review 9.  Osteocalcin. Biochemical considerations and clinical applications.

Authors:  J B Lian; C M Gundberg
Journal:  Clin Orthop Relat Res       Date:  1988-01       Impact factor: 4.176

10.  Expression of alkaline phosphatase loci in mammalian tissues.

Authors:  D J Goldstein; C E Rogers; H Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

View more
  39 in total

1.  COX2 inhibition reduces aortic valve calcification in vivo.

Authors:  Elaine E Wirrig; M Victoria Gomez; Robert B Hinton; Katherine E Yutzey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-02-26       Impact factor: 8.311

2.  A time course investigation of the statin paradox among valvular interstitial cell phenotypes.

Authors:  Elyssa L Monzack; Kristyn S Masters
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-17       Impact factor: 4.733

3.  M1 macrophages promote aortic valve calcification mediated by microRNA-214/TWIST1 pathway in valvular interstitial cells.

Authors:  Xiao-Fei Li; Yan Wang; Dong-Dong Zheng; Hai-Xia Xu; Teng Wang; Min Pan; Jia-Hai Shi; Jian-Hua Zhu
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

4.  Bone morphogenetic protein-4 and transforming growth factor-beta1 mechanisms in acute valvular response to supra-physiologic hemodynamic stresses.

Authors:  Ling Sun; Philippe Sucosky
Journal:  World J Cardiol       Date:  2015-06-26

5.  Crystallinity of hydroxyapatite drives myofibroblastic activation and calcification in aortic valves.

Authors:  Jennifer M Richards; Jennie A M R Kunitake; Heather B Hunt; Alexa N Wnorowski; Debra W Lin; Adele L Boskey; Eve Donnelly; Lara A Estroff; Jonathan T Butcher
Journal:  Acta Biomater       Date:  2018-03-02       Impact factor: 8.947

Review 6.  Mechanisms of calcification in aortic valve disease: role of mechanokinetics and mechanodynamics.

Authors:  W David Merryman; Frederick J Schoen
Journal:  Curr Cardiol Rep       Date:  2013-05       Impact factor: 2.931

7.  Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation.

Authors:  Jesper Hjortnaes; Claudia Goettsch; Joshua D Hutcheson; Gulden Camci-Unal; Lilian Lax; Katrin Scherer; Simon Body; Frederick J Schoen; Jolanda Kluin; Ali Khademhosseini; Elena Aikawa
Journal:  J Mol Cell Cardiol       Date:  2016-03-17       Impact factor: 5.000

Review 8.  Disease-inspired tissue engineering: Investigation of cardiovascular pathologies.

Authors:  LaTonya R Simon; Kristyn S Masters
Journal:  ACS Biomater Sci Eng       Date:  2019-10-29

Review 9.  In vitro models of aortic valve calcification: solidifying a system.

Authors:  Meghan A Bowler; W David Merryman
Journal:  Cardiovasc Pathol       Date:  2014-08-15       Impact factor: 2.185

10.  Shape-Specific Nanoceria Mitigate Oxidative Stress-Induced Calcification in Primary Human Valvular Interstitial Cell Culture.

Authors:  Yingfei Xue; Cynthia St Hilaire; Luis Hortells; Julie A Phillippi; Vinayak Sant; Shilpa Sant
Journal:  Cell Mol Bioeng       Date:  2017-07-25       Impact factor: 2.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.